The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Extramedullary disease (EMD): A common terminal pathway in multiple myeloma (MM) progression.
S. Z. Usmani
No relevant relationships to disclose
A. Mitchell
No relevant relationships to disclose
J. Szymonifka
No relevant relationships to disclose
J. D. Shaughnessy
No relevant relationships to disclose
A. Hoering
No relevant relationships to disclose
Y. Alsayed
No relevant relationships to disclose
S. Waheed
No relevant relationships to disclose
B. Nair
No relevant relationships to disclose
J. Crowley
No relevant relationships to disclose
B. Barlogie
No relevant relationships to disclose